2cureX AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0010468124
SEK
1.00
-0.3 (-23.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
2cureX AB
Why is 2cureX AB ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is 2cureX AB for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
2cureX AB
118.42%
0.57
371.83%
OMX Stockholm 30
8.01%
0.51
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.19%
EBIT Growth (5y)
-163.65%
EBIT to Interest (avg)
-27.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
38.28
EV to EBIT
-0.89
EV to EBITDA
-0.89
EV to Capital Employed
-7.42
EV to Sales
33.18
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-3081.80%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for 2cureX AB
Debtors Turnover Ratio
Highest at 0.09% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
At SEK 0.15 MM has Grown at 71.11%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK -8.85 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Net Profit
Highest at SEK -4.92 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK -0.28
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost
Fallen by -99.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for 2cureX AB
Operating Cash Flow
Lowest at SEK -32.46 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Cash and Eqv
Lowest at SEK 31.51 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio